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 Bile salt hydrolase levels and deconjugation rates vary with different probiotics. 













 Probiotics secrete bile salt hydrolase (BSH) which catalyses the deconjugation and 
excretion of bile salts in the GI tract altering cholesterol metabolism in the liver. Many 
probiotic preparations include prebiotics to promote probiotic growth but little is 
understood about how prebiotics affect BSH activity.  In this study the ability of 
probiotic Lactobacilli species to deconjugate bile salts in the presence of various 
prebiotics was determined by measuring cholic acid release. The kinetic properties of 
BSH was assessed to determine the impact the prebiotics on bile salt deconjugation.  
When L. acidophilus NCTC 1723 was incubated with inulin (1%) there was a 
significant (p<0.01) increase in cholic acid release by 0.16 nmol/min.  Lactulose and 
lactobionic acid at 1% decreased cholic acid release to 0.2 nmol/min and 0.06 nmol/min 
respectively. In the presence of the pure BSH, inulin and lactulose (0-6%) altered Km 
and Vmax of the enzyme with a Ki of 12% and 10.5% respectively. By contrast, 
lactobionic acid (2%) increased BSH activity two-fold (p<0.01).  
These results confirm that prebiotics are capable of altering BSH activity in vitro. 
Similar changes in vivo could potentially affect the claimed health benefits of synbiotics 
particularly where the desired outcome is lowering of serum cholesterol. 
 













Probiotics were first demonstrated to exhibit hypocholesterolemic effects in humans as 
early as 1963 [1-2]. The mechanism is thought to involve the metabolism of bile salts 
by intestinal bacteria reducing the amount of bile salts reabsorbed by enterohepatic 
circulation [3]. To compensate for the loss of bile salts there is an increase in bile salt 
biosynthesis from cholesterol in the liver, leading to a reduction in serum cholesterol 
levels. This shift in cholesterol metabolism by probiotics has been suggested to decrease 
the risk of cardiovascular disease and is thought by many to be one of the putative 
benefits of probiotics [4-7]. The metabolism of bile salts in the GI tract is dependent on 
the chemical form, for example, whether it is a primary or secondary bile salt, the level 
of conjugation and hydroxylation [8-10]. In terms of cholesterol metabolism, perhaps 
the most important bile salt modification takes place in the colon with the deconjugation 
of primary bile salts. Deconjugation is catalysed by bile salt hydrolase (BSH) enzymes 
secreted by gut bacteria including members of the genera, Bifidobacterium and 
Lactobacillus which account for the majority of bacterial species in probiotic 
preparations [11-14]. Deconjugation generally reduces the chances of bile salt 
reabsorption from the terminal ileum and increases faecal excretion [15-18].  The 
process of deconjugation involves hydrolysis of the C-24 N-acyl amide bond linking 
bile acids to their amino acid conjugates [19] thus liberating unconjugated bile salts [11, 
20].  
Bile salt deconjugation is now listed as one of the key selection criteria for probiotics 
[21]. Other proposed mechanisms by which probiotics could reduce serum cholesterol 
include binding of cholesterol to the probiotic cell membrane [22] and direct 
metabolism of cholesterol by probiotic cultures reducing the amount available to the 
host [23-24]. Products containing probiotics alone or in “synbiotic” combination with 









cardiovascular health [25-30]. The indigestible nature of prebiotics allow them to be 
able to reach the lower intestine and serve as substrates for probiotic growth in vivo 
[31]. Presently little is understood about how the prebiotics in “synbiotic” preparations 
affect bile salt and cholesterol metabolism. Prebiotics have also been shown to possess 
other properties which are independent of probiotic growth including inhibition of 
apoptosis of colon cells and reducing the level of genotoxicity [32]. 
 
Although a limited number of studies have been carried out on the synbiotic 
applications of prebiotics and probiotics very little is understood about how prebiotics 
impact on BSH activity, particularly on bile salt deconjugation [33-35]. In an attempt 
to determine how prebiotics could alter bile salt deconjugation and ultimately affect 
cholesterol metabolism, the BSH activity from five probiotic Lactobacilli species was 
assessed in the presence of various prebiotics. In addition, the basic enzyme kinetic 
properties of a typical BSH enzyme known as Choloylglycine hydrolase  (CGH) was 
also assessed in the presence of three widely used prebiotics. The results confirm a 
complex interaction between prebiotics and BSH activity and the potential to affect 
cholesterol metabolism. 
 
2. Materials and Methods 
2.1. Materials 
Inulin, lactulose, lactobionic acid, CGH and all chemicals including bile acids/ salts 
used in this study were of analytical grade and were obtained from Sigma-Aldrich, 
Dorset, UK. L. acidophilus NCTC 1723, and L. delbrueckii ss bulgaricus NCTC 12712, 
were purchased from National Collection of Type Cultures (NCTC), L. brevis NCIMB 









(NCIMB), L. acidophilus NCFM was a gift from Danisco, UK and L. reuteri NCIMB 
11951 was from UEL culture collection. Anaerobic incubation was achieved using CO2 
gaspaks in anaerobic jars (Sigma-Aldrich, Dorset, UK). 
 
2.2. Microorganisms, media and culture conditions 
 
The strains were maintained at -800C in 30% glycerol and initially grown anaerobically 
on MRS agar plates at 370C for 48 h. Growth of Lactobacillus cultures were achieved 
anaerobically in MRS broth overnight, 1% of the overnight culture was then introduced 
in the MRS medium supplemented with sodium salts of different bile salts (glycocholic, 
taurocholic, glycodeoxycholic, taurodeoxycholic, glycochenodeoxycholic and 
taurochenodeoxycholic acid) at concentrations ranging from 1-6 mM  to represent the 
concentration in the intestine [36-38]. Cultures were incubated 37˚C for 15h until the 
cells achieved a late exponential growth phase. The broth cultures (10 ml) were adjusted 
to pH 7 with 1M NaOH and centrifuged at 10,000 x g for 15 min at 5˚C. The cell pellet 
was discarded, and the supernatant broth adjusted to pH 1 with 10M HCL and 
deconjugation determined by thin layer chromatography. 
 
2.3. The detection of bile salt deconjugation by thin layer chromatography 
 
Deconjugated bile acids were determined by spotting 3μl of the supernatant from the 
broth cultures along with appropriate bile salt standards onto a 5cm x 20cm silica coated 
(0.25mm) TLC plate (Sigma-Aldrich, Dorset, UK), previously activated at 110˚C for 
10 min. Chromatograms were developed in glass tanks lined with filter paper saturated 









acetic acid (15:65:10:1) [39]. After development and drying, the plates were sprayed 
with vanillin-sulfuric acid reagent and heated at 120˚C as described by Stahl, 1965. 
Results were expressed as Rf values calculated using the formula x/y, where x is the 
distance moved from the point of application and y the solvent front. 
 
2.4. Determination of bile salt hydrolase activity 
 
The effect of varying concentrations of prebiotic on Lactobacilli BSH activity was 
measured as the rate of enzymatic hydrolysis of the C-24 N-acyl amide bond linking 
bile salts to release the free bile acid and the amino acid conjugate. In this study the 
release of free cholic acid from taurocholic was quantified as described by Liong and 
Shah (2005). Briefly, Lactobacillus acidophilus NCTC 1723 chosen for its ability to 
deconjugate taurocholic acid.  The overnight culture (1%) was introduced into MRS 
broth (10mL) and incubated at 37˚C for 15 h. The medium also contained either inulin, 
lactulose or lactobionic acid 0.5 – 2% and sodium taurocholic acid 6 mM as the most 
suitable bile acid substrate. At the end of the incubation the pH of the medium was 
adjusted to pH 7 with NaOH (1N) and centrifuged at 10,000 x g for 15min at 5˚C.  The 
cell pellet was discarded, and the supernatant broth adjusted to pH 1 with HCl (10N). 2 
mL ethyl acetate was added 1mL of the supernatant and the mixture was vortexed. The 
ethyl acetate layer was collected in a glass tube evaporated under a stream of nitrogen 
gas at 65˚C. The residue then dissolved in 1 ml 0.01N NaOH, once completely mixed 
6 ml of H2SO4 (16N) and 1ml  furfuraldehyde (1%) was added and the mixture boiled 
at 65˚C for 10 mins. On cooling, 5 mL glacial acetic acid was introduced and vortexed 
for 1 min prior to taking the absorbance reading at 660nm to determine the level of 









NaOH and for recovery cholic acid was dissolved in media and then treated as above. 
All experiments were repeated three times. 
 
2.5. The kinetic properties of Choloylglycine hydrolase in the presence of prebiotics 
 
Km, Vmax and Ki were determined by incubating CGH  (50 units) for 30 minutes at 37˚C 
with varying concentrations of taurocholic acid (0-6mM) in sodium phosphate buffer 
(pH 6.4). In a parallel series of studies 2, 4 and 6% inulin, lactulose or lactobionic acid 
0.5, 1 and 2% were introduced and incubated under the same conditions. The activity 




2.6. Statistical analysis 
 
Statistical analysis was performed using Graphpad prism version 4.0. One-way 
analysis of variance (ANOVA) at 95% confidence interval and a post tests Dunnett 
multiple comparison tests were used to determine significant differences on all data 
(according to the experimental design and runs). The differences were considered 















Following incubation in MRS broth supplemented with bile salts (1.5mM), growth was 
observed for cultures of L. acidophilus NCTC 1723, L. delbrueckii ss bulgaricus NCTC 
12712, L. brevis NCIMB 11973,  L. acidophilus NCFM and L. reuteri NCIMB 11951 
in glycocholic, taurocholic, taurodeoxycholic and taurochenodeoxycholic acid. No 
growth was observed in the presence of glycodeoxycholic acid and 
glycochenodeoxycholic acid  for cultures of L. acidophilus NCTC 1723 and L. 
delbrueckii ss bulgaricus NCTC 12712 (Table 1). There was also no growth for L. 
reuteri NCIMB 11951 in the presence of glycochenodeoxycholic acid (Table 1). 
 
3.2. Deconjugation of bile salts by L. acidophilus NCTC 1723 
 
Deconjugation of the bile salts was assessed using TLC and confirmed by comparing 
the Rf values to the pure conjugated bile salts and the appearance of the free bile acids 
in the medium.   L. acidophilus NCTC 1723 deconjugated the sodium salts of 
glycocholic, taurocholic, taurodeoxycholic and taurochenodeoxycholic acid (Table 2). 
However incomplete deconjugation was observed for glycocholic and 
taurodeoxycholic acid (Table 2) with both free and conjugated bile acids appearing on 
the TLC plate. Deconjugation was not observed for cultures of L. delbrueckii ss 
bulgaricus NCTC 12712, L. brevis NCIMB 11973, L. acidophilus NCFM and L. reuteri 
NCIMB 11951 despite growth in media containing the bile salts (Table 2). 
 
3.3. Effect of prebiotics on L. acidophilus NCTC 1723 growth  
 
The lowest growth of L. acidophilus NCTC 1723 was in the absence of both glucose 









the L. acidophilus NCTC 1723 cell number increased to 7.83 x 108 CFU/ml (Table 3). 
The addition of inulin at 1% or 2% to the media resulted in a slight increase in the 
number of L. acidophilus NCTC 1723 cells to 8.21 x 108 CFU/ml (p<0.05) and 8.32 x 
108 CFU/ml (p<0.05) respectively. By contrast, the presence of lactobionic acid the 
number was 7.0 x 108 CFU/ml (p<0.001) and 5.18 x 107 CFU/ml (p<0.001)  for 0.5% 
and 1% respectively. At 2% lactobionic acid no growth of L. acidophilus NCTC 1723 
was observed. With lactulose (0.5-2%) as the prebiotic, there was no significant change 
in cell growth when compared to glucose. 
 
3.4. Effect of prebiotics on L. acidophilus NCTC 1723 deconjugation activity 
 
The effect of prebiotics on L. acidophilus NCTC 1723 BSH activity was determined 
quantitatively by assaying for the corresponding release of cholic acid from taurocholic 
acid (6mM) (Figure 1). Cholic acid released following growth with glucose as the 
carbon source was 0.25 nmol/min, whereas with inulin at 1% there was significant 
increases in deconjugation with 0.42 nmol/min cholic acid (P<0.01) released. At 2% 
inulin deconjugation fell back to 0.28 x 10-2 nmol/min cholic acid released (P<0.05). 
By contrast both lactulose and lactobionic acid resulted in a decrease in BSH 
deconjugation activity with the greatest inhibition caused by 1% lactobionic acid with 
only 0.009 nmol/min (P<0.01) cholic acid released. At 2% lactulose cholic acid release 
was 0.066 nmol/min (P<0.01). 
 
3.5. Effects of prebiotics on the enzyme kinetic properties of bile salt hydrolase. 
 
Bile salt hydrolase activity was assessed using a pure sample of the bile salt hydrolysing 









lactulose, lactobionic acid) revealed contrasting results with either a concentration 
dependent increase or decrease in enzymatic activity (Table 4). There was no significant 
difference in CGH kinetic activity in the presence of inulin at 2%.  At higher 
concentrations (4 and 6% w/v) enzyme activity was inhibited by 12 and 27% 
respectively. Lineweaver burk plots showed uncompetitive inhibition at 4% inulin and 
mixed inhibition at 6% with a Ki of 12% (Table 4). The Vmax for the release of free bile 
acids decreased with increasing inulin concentrations from 25±3.7 to 17.24±4.3 
nmol/min, and Km values also decreased from 2.2±0.3, to 1.72±0.9 mM (Table 4). 
Similarly with lactulose (2, 4 and 6%) CGH enzyme activity was inhibited by 25, 32 
and 36% respectively was observed (Table 4). Lineweaver burk plots showed an 
uncompetitive inhibition at 2 and 4 % and mixed inhibition at 6%, the Ki was 10.5%. 
Vmax values decreased in increasing lactulose concentrations from 16.39±2.3 nmol/min, 
Km values decreased to 1.72±0.7 mM (Table 4).  With lactobionic acid at concentrations 
up to 2%, CGH activity increased dose dependently with Vmax increasing to 33.3±4.2 
nmol/min and 50±6.9 nmol/min at 1% and 2% respectively. Similarly Km values 





Although bile salt deconjugation is an accepted property of BSH enzymes, little is 
understood about how dietary ingredients and in particular prebiotics affect the kinetic 
properties of these essential enzymes. For individuals on certain diets particularly those 
with a high fibre content, high levels of prebiotics could reach the colon and impact on 









there are strong arguments to have a better understanding of how prebiotics could affect 
BSH kinetic activity, and potentially affect bile salt and serum cholesterol levels.  
Members of the genus Bifidobacterium and Lactobacillus, which are widely utilised as 
probiotics are a major source of BSH enzymes.  A number of studies have suggested 
that the activity of BSH produced by probiotics may play a role in regulating serum 
cholesterol in animal models and humans [33, 41-42]. The putative 
hypocholesterolaemic properties is one of the key arguments for the health benefits of 
probiotics.  In this study five Lactobacillus cultures (L. acidophilus NCTC 1723, L. 
delbrueckii ss bulgaricus NCTC 12712, L. brevis NCIMB 11973, L. acidophilus NCFM  
and L. reuteri NCIMB 11951) were shown to grow in high concentrations (1.5 - 6mM) 
of bile salts. The bacteria were also assessed for the ability to deconjugate bile salts 
presumably through the secretion of BSH. Of the five Lactobacilli cultures only L. 
acidophilus NCTC 1723 deconjugated the five bile salts used. This is not a totally 
surprising observation given the mutable nature of bacteria and confirms the need for 
constant testing to confirm any claimed properties of probiotics. No deconjugation was 
observed for L. acidophilus NCFM, L. brevis NCIMB 11973, L. delbrueckii ss 
bulgaricus NCTC 12712 and L. reuteri NCIMB 11951 although all are also widely used 
as probiotics. Variations in the ability of the different Lactobacilli species/strains to 
deconjugate bile salts has been known for some time. For example Brashears et al. 1998 
[43] showed that L. acidophilus 43121, Lactobacillus acidophilus L1, Lactobacillus 
casei N19 and Lactobacillus casei E5 cultures were capable of deconjugating 
taurocholic acid whilst others reported the inability of Lactobacilli species to 
deconjugate bile salts [44-45]. It is important to note that some of the variations in 
deconjugation reported in the literature might have been due to variations in study 








of conjugated bile acids used and differing assay conditions. However, the observations 
in this study confirm the need for caution when attributing general characteristics and 
specifically the ability to deconjugate bile salts to putative probiotics. 
 
Another key objective of this study was to assess if prebiotics could affect BSH 
deconjugation in general for which there is little information. In recent years prebiotics 
are often added alongside probiotic in what is termed synbiotic application. In this study 
the impact of prebiotics on bile salt deconjugation by L. acidophilus NCTC 1723 was 
assessed using taurocholic acid with either inulin, lactobionic acid or lactulose as the 
prebiotics.  All three prebiotics have been shown to possess differing ability to support 
the growth and functionality of probiotics [30,32]. Both inulin and lactulose slightly 
increased growth of L. acidophilus NCTC 1723 whereas lactobionic acid significantly 
decreased growth. The decreased growth caused by lactobionic acid can be attributed 
to the lowering of pH below pH 6 (data not shown) in the medium at concentrations 
above 0.5%, a factor that might be of importance should this compound be used in high 
concentrations as a prebiotic. The increased growth with inulin was not accompanied 
by increased deconjugation. For all three prebiotics used in this study deconjugation 
was reduced as the concentration increased. These results are in line with a study by 
Sridevi et al. 2009 [46] where the BSH activity varied with carbon source, pH and other 
and culture conditions.  These observations indicate that although prebiotics may 
promote probiotic growth under certain conditions, they could potentially have other 











Although these novel results demonstrate that prebiotics can interfere with the ability 
of probiotics to deconjugate bile salts, other factors must be considered, for example 
the impact on overall probiotic growth or the change in pH. In an attempt to determine 
if prebiotics directly alter BSH activity, kinetic studies were undertaken using CGH a 
commonly used commercially available bile salt hydrolysing enzyme [38]. Using 
taurocholic acid as the substrate, the rate of deconjugation appeared to follow simple 
Michaelis-Menten kinetics. Both inulin and lactulose demonstrated uncompetitive 
inhibition at 4% and mixed inhibition at 6%. The prebiotics also decreased apparent 
Vmax and Km with apparent Ki of about 12%. By contrast, lactobionic acid increased the 
ability of CGH to deconjugate taurocholic acid, doubling both Vmax and Km. The 
increased activity of lactobionic acid is probably due to the lower pH with increasing 
lactobionic acid concentrations. By contrast lower pH by the same prebiotic had a 
detrimental effect on cell viability. Previously a pH of 4 was reported as optimal for 
CGH activity, so these observations are in line with the activity of the enzyme [47]. 
BSH are generally released by probiotic bacteria into the lumen of the GI tract where 
they exert their effects. There is now evidence that changes in the gut microbiota will 
alter both BSH functionality and bile acid metabolism in vivo [48-49]  These results 
confirm that high level of prebiotics (up to 6%) will not only affect probiotic growth 
but could affect BSH activity in ways that are not always predictable. In considering 
the implications for the results it may possible that the effects observed for the taurine 
conjugated bile salts may be different, if only slightly  with glycine conjugated bile salts 
as a substrate.  
In conclusion, if bile salt deconjugation is a key requirement for probiotic 
classification then greater caution is needed when selecting species/strain [21]. There 









activity. The BSH kinetic observations in this study were based on experiments with 
purified BSH from Clostridium perfringens and may not necessarily be the same as if 
the BSH had been isolated from certain probiotics. 
These studies confirm that although certain bacteria species/strain are widely used as 
probiotics they may not always have the ability to support bile salt deconjugation.  
Similarly, prebiotics such as inulin may have benefits in terms of probiotic growth, 
however high levels may reduce BSH activity which could be affect bile salt and 
cholesterol metabolism. Where bile salt deconjugation is the primary objective with a 
view to lower serum cholesterol, a prebiotic such as lactobionic acid would be more 
effective probably through the lowering of colonic pH. However where probiotic 




Ethical Approval and Consent to participate: Not applicable 
 
Consent for publication: Not applicable 
 
Availability of supporting data: The datasets used and/or analysed during the 
current study are available from the corresponding author on reasonable request. 
 
Competing interests: The authors declare that they have no competing interests. 
 
Funding: All funding for all the authors came directly from the University of East 
London.  
 
Authors' contributions: WM, OA, OC participated in the overall planning of 
experiments, research design, data analysis & interpretation, and manuscript 
preparation. OA performed experimental studies of probiotics, enzyme kinetics. All 
authors read and approved the final manuscript. 
 










[1] Shaper AG, Jones KW,  Kyobe J: Serum lipids in the three nomadic tribes of 
Northern Kenya. American  Journal of Clinical  Nutrition 1963, 13:135–46. 
 
[2] Mann GV Studies of a surfactant and cholesterolemia in the Masai. American 
Journal of Clinical Nutrition 1974, 27: 464–9. 
 
[3] Tuohy KM, Fava F, Viola R  The way to a man’s heart is through his gut 
microbiota–dietary pro-and prebiotics for the management of cardiovascular 
risk. Proceedings of the Nutrition Society 2014, 73(02):172-85. doi: 
10.1017/S0029665113003911 
 
[4] Fava F, Lovegrove JA, Gitau R, Jackson KG, Tuohy KM: The gut microbiota and 
lipid metabolism: Implications for human health and coronary heart disease. Current 
Medical Chemistry 2006, 13: 3005–21. 
 
[5] Kumar M, Rakesh S, Nagpal  R, Ramakrishna RHA, Sudarshan V, Ramagoni R, 
Shujauddin M, Verma V, Kumar A, Tiwari A, Singh B, Kumar R: Probiotic 
Lactobacillus rhamnosus GG and Aloe vera gel improve lipid profiles in 
hypercholesterolemic rats. Nutrition 2013,  29: 574–9 
 
[6] Manson JE, Tosteson H, Ridker M, Satterfield S, Hebert P, O'Connor GT The 
primary prevention of myocardial infarction. New England Journal of Medicine 1992, 
326: 1406-16. 
 
[7] Reynier MO, Montet JC, Gerolami A, Marteau C, Crotte C, Montet AM, Mathieu 
S:  Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on 
micellar solubilization and intestinal absorption of cholesterol. Journal of  Lipid 
Research 1981, 22: 467-73. 
[8] Imray CHE, Radley S, Davis A, Barker G, Hendrickse CW, Donovan IA, Lawson, 
AM, Baker PR, Neoptolemos JP: Faecal unconjugated bile acids in patients with 
colorectal cancer or polyps. 1992 Gut, 33: 1239-45. 
[9] Bayerdorffer E, Mannes GA, Ochsenkuhn T, Dirschedl P, Wiebecke B, 
Paumgartner G: Unconjugated secondary bile acids in the serum of patients with 
colorectal adenomas. 1995 Gut, 36: 268-273. 
[10] Pereira MA, O’Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, 
Hallmans G, Knekt P,  Liu S: Dietary fiber and risk of coronary heart disease: a pooled 
analysis of cohort studies. Archives of Internal Medicine 2004, 164: 370–6. 
 
[11] Christiaens H,  Leer RJ,  Pouwels PH, Verstraete W: Cloning and expression of a 
conjugated bile acid hydrolase gene from Lactobacillus plantarum by using a direct 










[12] Elkins CA, Savage DC: Identification of genes encoding conjugated bile salt 
hydrolase and transport in Lactobacillus johnsonii 100-100. Journal of Bacteriology 
1998,180: 4344-9. 
 
[13] Midtvedt T, Norman A:  Bile acid transformations by microbial strains belonging 
to genera found in intestinal contents. Acta pathologica et microbiologica scandinavica 
1976, 71: 629–38. 
 
[14] Masuda N: Deconjugation of bile salts by Bacteroides and Clostridium. 
Microbiological Immunological 1981, 25: 1–11. 
 
[15] Eyssen H: Role of the gut microflora in metabolism of lipids and sterols. 
Proceeding of the Nutrition Society 1973,32: 59. 
 
[16] Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of 
atherosclerotic disease. New perspectives based on the Framingham study. Annals of  
Internal Medicine 1979,  90:85–91. 
 
[17] Pekkanen J, Linn S, Heiss G, Suchindran CM,  Leon A, Rifkind BM, Tyroler HA: 
Ten-year mortality from cardiovascular disease in relation to cholesterol level among 
mean with and without pre-existing cardiovascular disease. New England  Journal of  
Medicine 1990, 322: 1700–07. 
 
[18] Klaver FAM, Van der Meer R: The assumed assimilation of cholesterol by 
lactobacilli and Bifidobacterium bifidum is due to their salt-deconjugating activity. 
Applied Environmental Microbiology 1993, 59: 1120–1124. 
 
[19] Ridlon  JM, Kang D, and Hylemon PB: Bile salt biotransformations by human 
intestinal bacteria. The Journal of Lipid Research 2006, 47: 241-59. 
 
[20] De Smet I, Van Hoorde L, Van de Woestyne M, Cristiaens H, Verstraete W: 
Significance of bile salt hydrolytic activities of lactobacilli. Journal of Applied 
Bacteriology 1995, 79: 292–01. 
 
[21] Hill C,  Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani 
RB, Flint HJ, Salminen S, Calder PC, Sanders ME: Expert consensus document: The 
International Scientific Association for Probiotics and Prebiotics consensus statement 
on the scope and appropriate use of the term probiotic. National Reviews 
Gastroenterology & Hepatology 2014, 11: 506–14. 
 
[22] Noh DO, Kim SH, Gilliland SE: Incorporation of cholesterol into the cellular 
membrane of Lactobacillus acidophilus ATCC 43121. Journal of Dairy Science 1997, 
80: 3107–13.  
 
[23] Dambekodi PC, Gilliland SE: Incorporation of cholesterol into the cellular 









[24] Pereira DI, & Gibson GR: Cholesterol assimilation by lactic acid bacteria and 
bifidobacteria isolated from the human gut. Applied Environmental Microbiology 2002, 
68: 4689-93. 
[25] Michael DR,  Davies TS,  Moss JWE,  Lama Calvente, D, Ramji DP,  Marchesi, 
JR,  Pechlivanis A,  Plummer SF,  Hughes TR: The anti-cholesterolaemic effect of a 
consortium of probiotics: An acute study in C57BL/6J mice. Scientific Reports 2017, 
7, Article number: 2883 doi:10.1038/s41598-017-02889-5 
[26] Kim SH, Park SH, Sin H, Jang S, Lee S, Kim SY, Kwon B, Kang- Yu KY, Kim 
SY, and  Yang DY: Hypocholesterolemic Effects of Probiotic Mixture on Diet-
Induced Hypercholesterolemic Rats. Nutrients 2017, 9: 293-02. 
doi: 10.3390/nu9030293 
  
[27] Lye HS, Rusul G, Liong MT: Removal of cholesterol by lactobacilli via 
incorporation and conversion to coprostanol. J Dairy Science 2010, 93: 1383–1392. 
 
[28] Anderson JW, Gilliland SE: Effect of fermented milk (yogurt) containing 
Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. 
Journal of American College Nutrition 1999, 18: 43–50. 
 
[29] Sanders ME: Considerations for use of probiotic bacteria to modulate human 
health. Journal of Nutrition 2000, 130: 384-90. 
 
[30] Adebola O, Corcoran O, Morgan WA: Synbiotics: the impact of potential 
prebiotics inulin, lactulose and lactobionic acid on the survival and growth of 
lactobacilli probiotics. Journal of Functional Foods 2014, 10: 75-84. 
 
[31] Huebner J, Wehling RL, Hutkins RW: Functional activity of commercial 
prebiotics. International Dairy Journal 2007, 17: 770–5. 
[32] Adebola O, Corcoran O, Morgan WA: Protective effects of prebiotics inulin and 
lactulose from cytotoxicity and genotoxicity in human colon adenocarcinoma cells.  
Food Research International 2013, 52: 269-74. 
[33] Jarocki P, Podlesny M, Glibowski P, Targonski Z: Insight into the Physiological 
Role of Bile Salt Hydrolase among Intestinal Bacteria from the Genus Bifidobacterium. 
PLOS ONE 2014, DOI:10.1371/journal.pone.0114379. 
 
[34] Vyas, U, Ranganathan, N: Probiotics, Prebiotics, and Synbiotics: Gut and 
Beyond Gastroenterology Research and Practice.  
2012,http://dx.doi.org/10.1155/2012/872716. 
 
[35] Wang, J  Zhang,  H  Chen , X,  Chen, Y   Menghebilige,    Bao, Q: Selection of 
potential probiotic lactobacilli for cholesterol-lowering properties and their effect on 
cholesterol metabolism in rats fed a high-lipid diet. J. Dairy Sci. 2015, 9 5: 1645–










[36] Šušković J, Kos B, Matošić S, Besendorfer V: The effect of bile salts on survival 
and morphology of a potential probiotic strain Lactobacillus acidophilus M92. World 
Journal of Microbiology and Biotechnology 2000, 16: 673–78. 
[37] Walker DK & Gilliland SE:  Relationships Among Bile Tolerance, Bile Salt 
Deconjugation and Assimilation of Cholesterol by Lactobacillus acidophilus. Journal 
of Dairy Science 1993, 76: 956-961. 
 
[38] Liong MT & Shah NP: Bile salt deconjugation ability, bile salt hydrolase activity 
and cholesterol co-precipitation ability of lactobacilli strains. International. Dairy. 
Journal 2005, 15: 391-398. 
 
[39] Gilliland SE, Speck ML: Deconjugation of bile acids by intestinal lactobacilli. 
Applied Environmental Microbiology 1977, 33: 15–18.  
 
[40] Begley M, Hill C, Gohan CGM: Bile Salt Hydrolase Activity in Probiotics. 
Applied and Environmental Microbiology 2006, 72: (3) 1729-1738. 
doi:10.1128/AEM. 
 
[41] Guo CF, Li JY:  Hypocholesterolaemic action of Lactobacillus casei F0822 in rats 
fed a cholesterol-enriched diet. International Dairy Journal 2013, 32: 144-149. 
 
[42] Jones  ML, Martoni CJ, Parent M, Prakash S: Cholesterol-lowering efficacy of a 
microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 
yoghurt formulation in hypercholesterolaemic adults. British Journal of Nutrition 
2012, 107: 1505–1513. doi:10.1017/S0007114511004703. 
 
[43] Brashears MM, Gilliland SE, Buck LM: Bile Salt Deconjugation and Cholesterol 
Removal from Media by Lactobacillus casei.   Journal of Dairy Science 1998, 81: 2103–
2110. 
 
[44] Aries VJ, Crowther S, Drasar BS, Hill MJ:  Degradation of bile salts by human 
intestinal bacteria. Gut 1969, 10: 575. 
 
[45] Hil1 MJ, Drasar BS: Degradation of bile salts by human intestinal bacteria. Gut 
1968,  9: 22-27. 
 
[46] Sridevi N, Vishwe P, Prabhune A: Hypocholesteremic effect of bile salt hydrolase 
from Lactobacillus buchneri ATCC 4005. Food Research International 2009, 42: 516-
520. 
 
[47] Thomas LA, King A, French GL, Murphy GM, Dowling RH: Cholylglycine 
hydrolase and 7-dehydroxylase optimum assay conditions in vitro and caecal enzyme 
activities ex vivo. Clinica Chimica  Acta 1997, 268: 61-72. 
 
[48] Joyce  SA, MacSharry  J, Casey PG, Kinsella M, Murphy EF,  Shanahan F, Hill 








bile acid modification in the gut. PNAS 2014, 111 (20) 7421-7426. 
https://doi.org/10.1073/pnas.1323599111  
[49] Allegretti JR, Kassam Z, Mullish BH, Chiang A, Carrellas M, Hurtado J, 
Marchesi JR, McDonald JAK, Pechlivanis A, Barker GF,  et al. Effects of Fecal 
Microbiota Transplantation With Oral Capsules in Obese Patients.  Clin. 









Fig.1. Effect of varying prebiotic concentrations on L. acidophilus NCTC 1723 BSH activity. Bacteria 
cultured in media supplemented with 6mM taurocholic acid, 1% glucose and/or 0.5, 1 and 2% prebiotic. 
Each point represents the mean and SD of at least three determinations. Post test – Dunnetts multiple 























































































Table 1. Growth of L. acidophilus NCTC 1723, L. delbrueckii ss bulgaricus NCTC 12712, L. reuteri 
NCIMB 11951, L. brevis NCIMB 11973  and L. acidophilus NCFM in bile salts. Following 15 hr growth 
in glycocholic, taurocholic, glycodeoxycholic, taurodeoxycholic, glycochenodeoxycholic and 
taurochenodeoxycholic acid all at 1.5mM and the following growth patterns were observed – 
NEG –   No growth                           A - L. acidophilus NCTC 1723,                                        D – L. brevis NCIMB 11973 
+++   -    Profuse growth                  B - L.  delbrueckii ss bulgaricus NCTC 12712                 E – L. acidophilus NCFM LYO 10 
++     -   Minimal growth                  C - L. reuteri NCIMB 11951 
Bile acids (1.5mM)                            Growth 
                                                   A                        B                 C               D                 E 
 
Glycocholic                               +++                   +++               +++          +++            +++ 
 Taurocholic                              +++                   +++               +++          +++            +++ 
Glycodeoxycholic                     NEG                  NEG              +              +++            +++ 
Taurodeoxycholic                     +++                    ++                 +++          +++           +++ 
Glycochenodeoxycholic           NEG                   NEG             NEG         ++              ++ 










Table 2. Rf values of free and conjugated bile acids. Following 15 hr growth in media supplemented with 
glycocholic, taurocholic, glycodeoxycholic, taurodeoxycholic or taurochenodeoxycholic acid the ability 
of L. acidophilus NCTC 1723, L. delbrueckii ss bulgaricus NCTC 12712, L. reuteri NCIMB 11951, L. 
brevis NCIMB 11973 and L. acidophilus NCFM to deconjugate bile salts was assayed for on TLC plates.  
Bile acids/salts                    Rf values of free bile acids/ salts 
                                           Standards          A               B             C             D              E    
Cholic                                    0.35             0.35               -              -              -             - 
Chenodeoxycholic                 0.40            0.40               -              -              -              - 
Deoxycholic                          0.40             0.40               -              -              -              -   
Glycocholic                           0.20             0.20            0.20         0.20        0.20      0.20 
 Taurocholic                          0.13                -               0.13         0.13        0.13      0.13 
Glycodeoxycholic                 0.28              NG            NG          0.28        0.28      0.28 
Taurodeoxycholic                  0.10             0.10           0.10         0.10        0.10      0.10 
Taurochenodeoxycholic        0.15               -               0.15         0.15        0.15      0.15 
            
A    L. acidophilus NCTC 1723   
B    L. delbrueckii ss bulgaricus NCTC 12712    
C    L. reuteri NCIMB 11951 
D    L. brevis NCIMB 11973 
E    L. acidophilus NCFM LYO 10 
NG  No growth 














Table 3. Varying prebiotic concentration on growth of L. acidophilus NCTC 1723. Bacteria was cultured 
in media supplemented with 6mM taurocholic acid, 1% glucose and/or 0.5, 1 or 2% prebiotic. 
Table 3 
Glucose and/ or varying prebiotic            Conc. (%)                                          CFU/ml 
Glucose                                                     1.0                                           7.83 x 108     
                                      
Inulin                                                         0.5                                           8.07 x 108 
Inulin                                                         1.0                                           8.21 x 108* 
Inulin                                                         2.0                                           8.32 x 108* 
 
Lactulose                                                   0.5                                           7.85 x 108 
Lactulose                                                   1.0                                           8.08 x 108 
Lactulose                                                   2.0                                           8.07 x 108 
 
Lactobionic acid                                        0.5                                           7.0 x108* 
Lactobionic acid                                        1.0                                           5.18 x 107***         
Lactobionic acid                                        2.0                                            -     
 
No glucose or prebiotic                              0.0                                          5.95x 104*** 
Post test - Dunnetts multiple comparison tests (all data were compared against the control data without 









Table 4. The effect of varying prebiotic concentrations on CGH activity. Enzyme activity was determined 
by the extent of cholic acid released. The enzymatic activity of (CGH) was carried out in sodium 
hydrogen phosphate buffer containing taurocholic acid 1-5mM and 2, 4 and 6% prebiotic (inulin), 
(lactulose) or  0.5, 1 C 2%▲ lactobionic acid. Km and Vmax values were as determined by Lineweaver-
Burk plots.  
 
Prebiotic (%) 





0 - 2.2±0.3,  25.0±3.7,   
12.0 
 
2 7.65 2.5±0.4,  25.0±3.2,  
4 12.02* 1.7±0.1,  20.0±2.2,  
6 27.32** 1.7±0.9 17.2±4.3  
 
Lactulose 
0 - 2.2±0.3,  25.0±3.7,  
 
10.5 
2 25.16* 1.4±0.2, 20.0±2.8,  
4 32.43* 1.5±0.4,  16.7±1.9,  




0 - 2.2±0.3, 25.0±3.7,  
- 0.5 -17.32 2.0±0.1 26.3±1.7,  
1 -27.45* 2.9±0.3 33.3±4.2,  
2 -37.00** 4.3±0.5 50.0±6.9 
Post test - Dunnetts multiple comparison test (all data were compared against the control data without prebiotics 
with **p≤0.01 and * p<0.05) 
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